[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100635406":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":10,"centralContacts":22,"locations":10,"responsibleParty":28,"collaborators":10,"id":30,"slug":31,"hasResults":32,"nctId":33,"briefTitle":34,"officialTitle":34,"acronym":10,"eligibilityCriteria":35,"healthyVolunteers":32,"sex":36,"minAge":37,"maxAge":10,"enrollmentInfo":38,"targetDuration":41,"studyType":42,"phases":10,"briefSummary":43,"conditions":44,"keywords":51,"overallStatus":53,"whyStopped":10,"lastUpdateSubmitDate":54,"lastUpdatePostDateStruct":55,"startDateStruct":58,"completionDateStruct":60,"leadSponsor":62,"locationsCount":10},{"fullName":5,"class":6},"Philips Clinical & Medical Affairs Global","INDUSTRY",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Prospective Observational",null,"Prospective observational subjects undergoing planned cardiac procedures utilizing VeriSight image guidance",[13],"Device: ICE Image Guidance",[15],{"type":16,"name":17,"description":18,"armGroupLabels":19,"otherNames":20},"DEVICE","ICE Image Guidance","VeriSight PRO ICE image guidance",[9],[21],"VeriSight",[23],{"name":24,"role":25,"phone":26,"phoneExt":10,"email":27},"Lucianno Mazzaro, MS","CONTACT","952-266-9969","luciano.mazzaro@philips.com",{"type":29,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR","100635406","hummingbird-ice-study-100635406",false,"NCT07552272","Hummingbird ICE Study","Inclusion Criteria:\n\n* 18 years of age\n* Willing to provide written, dated and signed, informed consent\n* Undergoing percutaneous cardiac intervention procedures in with VeriSight Pro is used\n\nExclusion Criteria:\n\n* Contraindicated for ICE catheter placement or considerations that make placement of VeriSight not technically feasible\n* Known contraindicated conditions include sepsis, major coagulation abnormalities, presence of any intracardiac thrombus, presence of class IV angina or heart failure, deep vein thrombosis, or significant peripheral vascular disease","ALL","18 Years",{"count":39,"type":40},1000,"ESTIMATED","2 Days","OBSERVATIONAL","The goals of this observational study are to collect data and ultrasound images using the Philips VeriSight Pro intracardiac echocardiography (ICE) catheter to assess safety and effectiveness and to support development efforts of the VeriSight Pro imaging platform.",[45,46,47,48,49,50],"ATRIAL APPENDAGE CLOSURE for ATRIAL FIBRILLATION","Atrial Fibrillation (AF)","Valve Disease, Heart","Atrial Septal Defect","Patent Foramen Ovale","Tricuspid Valve Disease",[52,21],"Intracardiac Echocardiography (ICE)","NOT_YET_RECRUITING","2026-05-18",{"date":56,"type":57},"2026-05-22","ACTUAL",{"date":59,"type":40},"2026-07",{"date":61,"type":40},"2031-07",{"name":5,"class":6}]